NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 315 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,816 | -44.8% | 20,832 | -30.8% | 0.00% | -25.0% |
| Q1 2023 | $1,670,264 | +9.9% | 30,084 | -20.5% | 0.00% | +33.3% |
| Q4 2022 | $1,520,394 | -0.5% | 37,849 | +8.6% | 0.00% | -25.0% |
| Q3 2022 | $1,528,000 | +35.0% | 34,861 | +9.1% | 0.00% | +33.3% |
| Q2 2022 | $1,132,000 | +6.1% | 31,940 | +21.8% | 0.00% | +50.0% |
| Q1 2022 | $1,067,000 | -63.7% | 26,228 | -16.7% | 0.00% | -66.7% |
| Q4 2021 | $2,941,000 | -26.3% | 31,489 | -12.0% | 0.01% | -40.0% |
| Q3 2021 | $3,988,000 | +1.6% | 35,784 | +3.5% | 0.01% | 0.0% |
| Q2 2021 | $3,926,000 | +82.3% | 34,583 | +63.0% | 0.01% | +42.9% |
| Q1 2021 | $2,154,000 | -63.3% | 21,214 | -64.0% | 0.01% | -63.2% |
| Q4 2020 | $5,868,000 | +359.2% | 58,960 | +233.2% | 0.02% | +280.0% |
| Q3 2020 | $1,278,000 | +108.8% | 17,694 | +44.0% | 0.01% | +66.7% |
| Q2 2020 | $612,000 | – | 12,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |